Piracetam as a Therapeutic Agent for Doxorubicin-Induced Cognitive Deficits by Enhancing Cholinergic Functions and Reducing Neuronal Inflammation, Apoptosis, and Oxidative Stress in Rats

Cancer chemotherapy is known to cause cognitive defects in patients. Our study investigated the effect of piracetam (PIRA; 200 or 400 mg/kg) against doxorubicin (DOX)-induced cognitive deficits in a rat model. The cognitive parameters were analyzed using elevated plus-maze, novel object recognition, and Y-maze tests. Acetylcholinesterase (AChE), neuroinflammatory mediators (cyclooxygenase-2 (COX-2), prostaglandin E2 (PGE2), nuclear factor-κB (NF-κB), tumor necrosis factor-alpha (TNF-α)), apoptotic proteins (B-cell lymphoma-2 (Bcl-2), Bcl2 associated X protein (Bax), cysteine aspartate specific protease-3 (caspase-3)), oxidative parameters (malondialdehyde (MDA), catalase (CAT), and glutathione (GSH)) were also determined in the brain. PIRA administration offered significant protection against DOX-induced cognitive deficits in all maze tests and restored cholinergic functions via a significant reduction in AChE levels. Additionally, PIRA suppressed DOX-induced neuroinflammatory mediators (COX-2, PGE2, NF-κB, and TNF-α), pro-apoptotic proteins (Bax and caspase-3), and oxidative stress (MDA). Besides, it facilitated antioxidant (CAT and GSH) levels. Hence, our study highlighted that the neuroprotective activity of PIRA against DOX-induced cognitive deficits can be linked to reductions of AChE levels, neuro-inflammatory mediators, pro-apoptotic proteins, and oxidative stress.

[1]  M. Arfeen,et al.  Levetiracetam Ameliorates Doxorubicin-Induced Chemobrain by Enhancing Cholinergic Transmission and Reducing Neuroinflammation Using an Experimental Rat Model and Molecular Docking Study , 2022, Molecules.

[2]  M. Arfeen,et al.  Sukkari dates seed improves type-2 diabetes mellitus-induced memory impairment by reducing blood glucose levels and enhancing brain cholinergic transmission: In vivo and molecular modeling studies , 2022, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[3]  Mariola Herbet,et al.  Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis , 2021, International journal of molecular sciences.

[4]  V. Mani.  Betahistine Protects Doxorubicin-Induced Memory Deficits via Cholinergic and Anti-Inflammatory Pathways in Mouse Brain , 2021, International Journal of Pharmacology.

[5]  S. Qiu,et al.  Kai-Xin-San Attenuates Doxorubicin-Induced Cognitive Impairment by Reducing Inflammation, Oxidative Stress, and Neural Degeneration in 4T1 Breast Cancer Mice , 2021, Evidence-based complementary and alternative medicine : eCAM.

[6]  Xin Liu,et al.  Doxorubicin-Induced Cognitive Impairment: The Mechanistic Insights , 2021, Frontiers in Oncology.

[7]  Y. Khadrawy,et al.  PROTECTIVE EFFECT OF NANOCURCUMIN AGAINST NEUROTOXICITY INDUCED BY DOXORUBICIN IN RAT'S BRAIN. , 2021, Neurotoxicology.

[8]  H. El-Mesallamy,et al.  Berberine ameliorates doxorubicin-induced cognitive impairment (chemo brain) in rats. , 2021, Life sciences.

[9]  M. Tolba,et al.  Caffeic acid phenethyl ester counteracts doxorubicin-induced chemobrain in Sprague-Dawley rats: Emphasis on the modulation of oxidative stress and neuroinflammation , 2020, Neuropharmacology.

[10]  Kalaiselvi Sivalingam,et al.  Neuroprotective Effect of Piracetam against Cocaine-Induced Neuro Epigenetic Modification of DNA Methylation in Astrocytes , 2020, Brain sciences.

[11]  Zhong-Ping Feng,et al.  Doxorubicin chemotherapy-induced "chemo-brain": Meta-analysis. , 2020, European journal of pharmacology.

[12]  Kaijie Wang,et al.  Polydatin ameliorates chemotherapy-induced cognitive impairment (chemobrain) by inhibiting oxidative stress, inflammatory response, and apoptosis in rats , 2020, Bioscience, biotechnology, and biochemistry.

[13]  E. Li,et al.  Dexmedetomidine reduces the inflammation and apoptosis of doxorubicin-induced myocardial cells. , 2020, Experimental and molecular pathology.

[14]  R. L. Pagano,et al.  Poldip2 mediates blood-brain barrier disruption in a model of sepsis-associated encephalopathy , 2019, Journal of Neuroinflammation.

[15]  Liang-Jun Yan,et al.  Role of Catalase in Oxidative Stress- and Age-Associated Degenerative Diseases , 2019, Oxidative Medicine and Cellular Longevity.

[16]  Jian-lei Yuan,et al.  Geniposide Alleviates Traumatic Brain Injury in Rats Via Anti-Inflammatory Effect and MAPK/NF-kB Inhibition , 2019, Cellular and Molecular Neurobiology.

[17]  V. Mani,et al.  Ameliorative effect of metformin on cyclophosphamide-induced memory impairment in mice. , 2019, European review for medical and pharmacological sciences.

[18]  P. Guest,et al.  The Y-Maze for Assessment of Spatial Working and Reference Memory in Mice. , 2018, Methods in molecular biology.

[19]  A. Zabala,et al.  Cognitive improvement of acetylcholinesterase inhibitors in schizophrenia , 2018, Journal of psychopharmacology.

[20]  S. Yıldırım,et al.  Morin attenuates doxorubicin-induced heart and brain damage by reducing oxidative stress, inflammation and apoptosis. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[21]  D. Butterfield,et al.  Doxorubicin-induced elevated oxidative stress and neurochemical alterations in brain and cognitive decline: protection by MESNA and insights into mechanisms of chemotherapy-induced cognitive impairment (“chemobrain”) , 2018, Oncotarget.

[22]  S. Azab,et al.  Astaxanthin Ameliorates Doxorubicin-Induced Cognitive Impairment (Chemobrain) in Experimental Rat Model: Impact on Oxidative, Inflammatory, and Apoptotic Machineries , 2018, Molecular Neurobiology.

[23]  Parul Gupta,et al.  New therapeutic activity of metabolic enhancer piracetam in treatment of neurodegenerative disease: Participation of caspase independent death factors, oxidative stress, inflammatory responses and apoptosis. , 2018, Biochimica et biophysica acta. Molecular basis of disease.

[24]  M. Mesulam,et al.  The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. , 2018, Brain : a journal of neurology.

[25]  Sarika Singh,et al.  Metabolic Enhancer Piracetam Attenuates the Translocation of Mitochondrion-Specific Proteins of Caspase-Independent Pathway, Poly [ADP-Ribose] Polymerase 1 Up-regulation and Oxidative DNA Fragmentation , 2018, Neurotoxicity Research.

[26]  J. Xu,et al.  Study on the mechanism of JAK2/STAT3 signaling pathway-mediated inflammatory reaction after cerebral ischemia , 2018, Molecular medicine reports.

[27]  Shao-Cong Sun,et al.  NF-κB signaling in inflammation , 2017, Signal Transduction and Targeted Therapy.

[28]  G. Ramalingayya,et al.  Rutin protects against neuronal damage in vitro and ameliorates doxorubicin-induced memory deficits in vivo in Wistar rats , 2017, Drug design, development and therapy.

[29]  D. S. St. Clair,et al.  Dysregulation of cytokine mediated chemotherapy induced cognitive impairment , 2017, Pharmacological research.

[30]  A. Tripathi,et al.  Piracetam Attenuates LPS-Induced Neuroinflammation and Cognitive Impairment in Rats , 2017, Cellular and Molecular Neurobiology.

[31]  K. Friedland,et al.  Enhanced Neuroplasticity by the Metabolic Enhancer Piracetam Associated with Improved Mitochondrial Dynamics and Altered Permeability Transition Pore Function , 2016, Neural plasticity.

[32]  A. Azab,et al.  Psychotropic drugs attenuate lipopolysaccharide-induced hypothermia by altering hypothalamic levels of inflammatory mediators in rats , 2016, Neuroscience Letters.

[33]  Tilman Grune,et al.  Clinical Relevance of Biomarkers of Oxidative Stress , 2015, Antioxidants & redox signaling.

[34]  D. Butterfield,et al.  Superoxide induces protein oxidation in plasma and TNF-α elevation in macrophage culture: Insights into mechanisms of neurotoxicity following doxorubicin chemotherapy. , 2015, Cancer letters.

[35]  L. Cherney,et al.  Therapies for Cognitive Deficits Associated With Chemotherapy for Breast Cancer: A Systematic Review of Objective Outcomes. , 2015, Archives of physical medicine and rehabilitation.

[36]  T. Ahles,et al.  Doxorubicin and cyclophosphamide induce cognitive dysfunction and activate the ERK and AKT signaling pathways , 2015, Behavioural Brain Research.

[37]  M. Bocca,et al.  Effects of acute administration of melatonin on attentional, executive, and working memory processes in rats , 2015, Fundamental & clinical pharmacology.

[38]  H. Walczak.  Death receptor-ligand systems in cancer, cell death, and inflammation. , 2013, Cold Spring Harbor perspectives in biology.

[39]  Mona G. Amer,et al.  Epicatechin attenuates doxorubicin-induced brain toxicity: Critical role of TNF-α, iNOS and NF-κB , 2011, Brain Research Bulletin.

[40]  A. Gilmore,et al.  Bcl-2 proteins and mitochondria--specificity in membrane targeting for death. , 2011, Biochimica et biophysica acta.

[41]  G. Dewson,et al.  Molecular biology of Bax and Bak activation and action. , 2011, Biochimica et biophysica acta.

[42]  K. Hermelink.  Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer , 2011, Cancer.

[43]  Jitbanjong Tangpong,et al.  Doxorubicin-induced central nervous system toxicity and protection by xanthone derivative of Garcinia Mangostana , 2011, Neuroscience.

[44]  E. Kitraki,et al.  Corticosterone-regulated actions in the rat brain are affected by perinatal exposure to low dose of bisphenol A , 2010, Neuroscience.

[45]  Cristina Carvalho,et al.  Doxorubicin: the good, the bad and the ugly effect. , 2009, Current medicinal chemistry.

[46]  Edward Chu,et al.  A history of cancer chemotherapy. , 2008, Cancer research.

[47]  J. M. Silvers,et al.  Automation of the novel object recognition task for use in adolescent rats , 2007, Journal of Neuroscience Methods.

[48]  Yang Li,et al.  Matrine induces apoptosis in angiotensin II‐stimulated hyperplasia of cardiac fibroblasts: effects on Bcl‐2/Bax expression and caspase‐3 activation , 2007, Basic & clinical pharmacology & toxicology.

[49]  B. Winblad.  Piracetam: a review of pharmacological properties and clinical uses. , 2006, CNS drug reviews.

[50]  Nicoletta Pellegrini,et al.  A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. , 2005, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[51]  Y. El-Sayed,et al.  All-trans-retinoic acid ameliorates doxorubicin-induced cardiotoxicity: in vivo potential involvement of oxidative stress, inflammation, and apoptosis via caspase-3 and p53 down-expression , 2017, Naunyn-Schmiedeberg's Archives of Pharmacology.

[52]  W. N. Chen,et al.  Pharmacogenetics of target genes across doxorubicin disposition pathway: a review. , 2010, Current drug metabolism.

[53]  S. Legrand-Poels,et al.  NF-kappaB activation by reactive oxygen species: fifteen years later. , 2006, Biochemical pharmacology.

[54]  A. Malykh,et al.  Piracetam and Piracetam-Like Drugs From Basic Science to Novel Clinical Applications to CNS Disorders , 2022 .